Better Data Collection is Key to Addressing EHR and Claims Data Discordance
Better Data Collection is Key to Addressing EHR and Claims Data Discordance
“There is a moderate agreement between EHR data and Medicare Part D (MPD) claims data for the receipt of oral anticancer agents, which are a popular treatment option for cancer patients, according to a study published in JAMA Network Open.
The study, conducted by the Texas Cancer Registry and The University of Texas MD Anderson Cancer Center (MDACC), found that 73.8 percent of the EHR data and MPD claims data overlapped, with 176 data sets shown in both and 123 sets not shown for either.
Oral anticancer agents are becoming more popular and equally as expensive, leaving policymakers to uncover data about how patients use them, which then allows for regulatory decision making.
Because the agreement percentage was moderate, this makes it tough on lawmakers to establish accurate reimbursement models or other health policies.
“The moderate rate of agreement (ie, 73.8 percent) found in this study may be because of various reasons,” wrote the authors of the study. “The EHR may be missing oral anticancer use for patients receiving only a consultation or because of incomplete medication reconciliation or medical record information. Claims in MPD may be missing because patients could obtain medications by other means that do not result in an MPD claim, including discount or other assistance programs.”
This study looked at 170 Medicare Part D members age 65 years or older at MDACC who had breast, prostate, kidney, or colon cancer or chronic myeloid leukemia. The analysis looked at 208 EHRs and 250 Part D claims from between 2007 and 2012.
Researchers examined both the intricacies of the EHR and the MPD claims data to identify any use of an oral anticancer agent. Because this specific EHR did not have a prescription order entry, researchers examined the MPD claims data to see if the prescriptions were filled.
Disagreement occurred 26.2 percent of the time. Seventy-four MPD claims (18.3 percent) were not found in the EHR, and 32 EHR drugs (7.9 percent) were not found in the MPD…”
Read the rest of the article on EHR Intelligence.
Be The First To Comment!
New comments are no longer accepted on this article.